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ThermodynamicsTransient receptor potential (TRP) proteins are a family of ion channels central for sensory signaling. These recep-
tors and, in particular, those involved in thermal sensing are also involved in pain signaling. Noteworthy,
thermosensory receptors are polymodal ion channels that respond to both physical and chemical stimuli, thus
integrating different environmental clues. In addition, their activity is modulated by algesic agents and lipidergic
substances that are primarily released in pathological states. Lipids and lipid-likemolecules have been found that
can directly activate some thermosensory channels ormodulate their activity by either potentiating or inhibiting
it. To date, more than 50 endogenous lipids that can regulate TRP channel activity in sensory neurons have been
described, thus representing the majority of known endogenous TRP channel modulators. Lipid modulators of
TRP channels comprise lipids from a variety of metabolic pathways, includingmetabolites of the cyclooxygenase,
lipoxygenase and cytochrome-P450 pathways, phospholipids and lysophospholipids. Therefore, TRP-channels
are able to integrate and interpret incoming signals from the different metabolic lipid pathways. Taken together,
the large number of lipids that can activate, sensitize or inhibit neuronal TRP-channels highlights the pivotal role
of these molecules in sensory biology as well as in pain transduction and perception. This article is part of a Spe-
cial Issue entitled: Lipid–protein interactions. Guest Editors: Amitabha Chattopadhyay and Jean-Marie
Ruysschaert.
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Survival of organisms critically depends on sensing environmental
signals and transducing the information to the brain for proper re-
sponse. For this purpose, the peripheral nervous system has specializedtein interactions. Guest Editors:
lecular y Celular, Universidad
he (Alicante), Spain. Tel.: +34
ez-Carvajal), aferrer@umh.esneurons that contain the sensing molecular machinery, namely ion
channels that respond to chemical and physical stimuli. An important
family of sensory channels is the Transient Receptor Potential (TRP).
These are non-selective cation channels, which are organized in six sub-
families, namely Ankyrin (TRPA), Canonical (TRPC), Melastatin (TRPM),
Mucolipin (TRPML), Polycistin (TRPP) and Vanilloid (TRPV) [1–4]. In
sensory neurons, they contribute to a plethora of activities including
thermal sensation, homeostasis of body temperature and pain [5,6]. In
the central nervous system (CNS), TRP channels have been associated
with neurogenesis, brain development and synaptic transmission
[7,8]. Moreover, TRPV1 and TRPA1 have also been related to immuni-
ty, obesity and thermogenesis [9]. Therefore, it is not surprising that
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[10].
Structurally, TRP channels are tetrameric assemblies of basic sub-
units organized around a central aqueous pore. Akin to voltage-gated
K+ channels, each subunit is composed of a membrane region contain-
ing 6 transmembrane segments. The recent structural model derived
from cryo-electron microscopic images has clearly shown this molecu-
lar analogy [11]. TRP channels mainly differ in their cytosolic N- and
C-terminal domains, which are involved in channel gating and mediat-
ing intracellular signaling. Indeed, most of TRP channels, if not all, are
part of protein complexes known as signalplexes [12–14].
TRPs are activated by amyriad of physical and chemical stimuli such
as temperature, pressure, voltage, irritant agents, inﬂammatory mole-
cules, pH, osmolality changes, UVB radiation and a large list of natural
chemical compounds [2,5,6,15–17]. TRP-evoked ionic currents are
pivotal for the modulation of action potential in peripheral terminals,
and to modify signaling pathways. Notably, TRP channel functionality
is modulated by intracellular signaling pathways such as those mediat-
ed by protein kinase C (PKC), protein kinase A (PKA) and phospholipase
C (PLC) [6,18]. This interplaymakes TRP channels highly dynamic signal
integrators whose activity depends on the cellular context and state.
As integral membrane proteins, TRP channels are highly sensitive to
the lipid environment, although studies in reconstituted controlled sys-
tems are still scarce. Furthermore, some potent TRP agonists are lipids.
The effect of lipids on TRP channels function has attracted the interest
of the pharmaceutical industry and the academic research, as reﬂected
by the number of research articles and reviews of this ﬁeld [19–23].
A great variety of channels, including TRPs, is modulated by endog-
enous and exogenous lipids [21,24–29]. Cholesterol has been reported
to potentiate or diminish the activity of ion channels [30]. Phos-
phatidylinositol 4-5-bisphosphate (PIP2) is a special case since it mod-
ulates the activity of many types of ion channels in a variety of modes
[31–33]. A notable interest is currently centered on understanding the
structure–function relations for TRP–lipid interactions. Information on
the functional and structural interactions between lipids and TRP chan-
nels offers mechanistic insights into TRP-mediated cellular processes.
Furthermore, such knowledgemay shed light into pathological process-
es, and the structural information may be utilized to pave the way to
develop TRP channelmodulatorswith therapeutic potential. The history
of lipid studies in the TRP ﬁeld started in the late 1990s [34–36], and
knowledge has thus far expanded to cover various aspects such as
ligand binding, sensitivity shift, bilayer-protein interactions, and up-
stream metabotropic signaling. However, it has not been established
yet whether TRP–lipid interactions act as second messengers, intercel-
lular transmitters, or function to simply transform the plasma mem-
brane properties affecting channel protein structure.
To date, more than 50 endogenous lipids that can regulate TRP chan-
nel activity in sensory neurons have been described, thus representing
the majority of known endogenous TRP channel modulators (Fig. 1).
Lipid modulators of TRP channels comprise lipids from a variety of
metabolic pathways, including metabolites of the cyclooxygenase
(COX), lipoxygenase (LOX) and cytochrome-P450 (CYP) pathways,
phospholipids and lysophospholipids [37–40]. In addition, recent
studies have identiﬁed lipid families previously not known to be
connected to sensor signaling as modulators of TRP channels. These
newly identiﬁed lipid modulators belong to hepoxilin A3 [41], 9-(S)-
hydroxyoctadecadienoic acid (9-(S)-HODE) and 13-(S)-HODE from
the LOX-pathway [42,43], 5(6)-epoxy-8Z,11Z,14Z-eicosatrienoic acid
(5,6-EET) from the CYP-pathway and 20-hydroxyeicasatetraenoic acid
(20-HETE) an α-hydroxide of arachidonic acid (AA) [44,45], as well as
the lysophosphatidic acid (LPA) [46]. Furthermore, molecules like the
LOX-derived ω-3 lipid Resolvin D1 (RvD1) and Resolvin D2 (RvD2) act
as endogenous inhibitors of TRPA1, TRPV1, TRPV3 and TRPV4 [47],
thus expanding the functionality of lipid-mediated TRP channel modu-
lation. Therefore, TRP-channels are able to integrate and interpret
incoming signals from the different metabolic lipid pathways. Takentogether, the large number of lipids that can activate, sensitize or inhibit
neuronal TRP-channels highlights the pivotal role of these molecules
in sensory biology as well as in pain transduction and perception.
Here we review the current state of this exciting topic in classical
thermoTRP biology, focusing on the structure-function data for
TRP channels regulation by different lipid mediators such as lipid
metabolites, phosphoinositides and components of lipid rafts. Novel
thermosensory channels (TRPM2, TRPM3 and TRPM5) have been
excluded because of yet limited data.
2. Lipid metabolites as modulators of TRP channel function
Original efforts to deorphanize TRPV1 channels [63] suggested that
endocannabinoids, such as anandamide, were TRPV1 agonists [35].
Later, N-arachidonoyl-dopamine (NADA) and the N-oleyl-dopamine
(OLDA) [38,60] were also determined to be TRPV1 agonists. Lipidergic
endovanilloids may bind to the intracellular receptor side like capsaicin
but compelling evidence is yet lacking. Similarly, nonpsychoactive can-
nabinoids such as cannabidiol and cannabinol have been described as
TRPV2 agonists [64]. These results suggested that lipid metabolites
may be critical modulators of TRP channel function.
Lipids from cell membranes can bemetabolized by Phospholipase A2
(PLA2) which release free polyunsaturated fatty acids (PUFAs) and
lysophospholipids (LPLs) or by PLC that produce Diacylglycerol (DAG)
and Inositol trisphosphate (IP3) (Fig. 2). PUFAs can be additionally
metabolized by COX, LOX and CYP enzymes given a plethora of lipids
molecules able to modulate thermoTRP channels activity [65]. LPLs
produced by PLA2 are also able to regulate the activity of TRP channels.
For instance, LPA, increased upon tissue injury, activates TRPV1 through
a directmechanism by apparently interactingwith the channel C termi-
nus [46], indicating a key role of this lipid in pain transduction.
Other LPLs that have been shown to modulate TRP channels
are lysophosphatidylcholine (LPC), lysophosphatidylinositol (LPI),
and lysophosphatidylserine (LPS) that alter the thermal sensitivity of
TRPM8, raising the temperature threshold toward normal body temper-
ature. This positive modulation by LPLs provides a potential physiolog-
ical mechanism for sensitizing and activating TRPM8 in the absence
of temperature variations [56,66]. However, direct binding of these
lipidergic metabolites to TRPM8 has not yet been demonstrated; and,
LPLsmay just affect the plasmamembrane physico-chemical properties
and thus indirectly inﬂuence channel gating.
LPC and LPI are also able to induce calcium inﬂux via TRPV2
channel [67]. This activation, which involves Gq/Go-protein and
phosphatidylinositol-3,4 kinase (PI3,4K) signaling, appears to bemainly
due to TRPV2 translocation to the plasma membrane and is dependent
on the length of the side-chain and the nature of the lysophospholipid
head-group. A potential pathological role of TRPV2 activation by LPC
and LPI has been suggested in prostate cancer as it increases cell migra-
tion of the prostate cancer cell line PC3 [67].
Diacylglycerol is a signaling molecule generated by Gq-coupled
GPCR receptors. DAG activates TRPV1 in a membrane-delimited
manner [59]. Multiple DAG analogues, 1-oleoyl-2-acetyl-snglycerol
(OAG), 1-Stearyl-2-arachinonyl-sn-glycerol (SAG), and 1,2-dioctanoyl-
sn-glycerol (DOG) have this capability but with different potencies
[59]. This activation is likely due to direct binding of the lipid to the
channel because DAG downstream signaling such as DAG lipase and
TRPV1 phosphorylation byDAG-activated protein kinase is not involved.
More relevant, a TRPV1 mutant channel unable to bind capsaicin does
not react with DAG. Diacylglycerol is also a TRPA1 activator and may
contribute to the downstream mechanism of GPCR-induced pain [48].
Endogenous TRPV1 lipid ligands also include LOX metabolites
such as 12-(S)-hydroperoxyeicosa-5Z,8Z,10E,14Z-tetraeonic acid 12-
(S)HPETE, 15-(S)HPETE and leukotriene B4 (LKB4) [36]. The signaling
leading to LOX metabolites includes bradykinin (BK) stimulation of
the B2 receptor and PLA2 activation [68]. BK-induced excitation of
sensory neurons via TRPV1 has been proposed to involve mobilization
Fig. 1. Lipidergic metabolites that activate (blue) or inhibit (red) TRP channels. References: [48] for arachidonic acid and OAG (TRPA1); [49] for PGA1, PGA2 (TRPA1); [50] for nitrooleic
acid (TRPA1); [51,52] for PIP2 (TRPA1); [45] for 5,6-EET (TRPA1); [53] for Resolvin D1 (TRPA1, TRPV3 and TRPV4); [47] for Resolvin D1, D2 and E1 (TRPA1, TRPV1); [54] for nitrooleic acid
OA-NO2 (TRPA1,TRPV1); [55] for PIP2 (TRPM8); [56] for LPC, LPI, LPS, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and arachidonic acid (AA) (TRPM8); [57] for 5,6-EET and
8,9-EET epoxyeicosatrienoic acids (TRPV4, TRPA1); [58] for FPP (TRPV3); [36] for 12(S)-HPETE, 15(S)-HPETE, 5(S)-HETE and leukotriene B4 (TRPV1); [35,36] for anandamide (TRPV1);
[59] for OAG (1-oleoyl-2-acetyl-snglycerol), SAG (1-Stearyl-2-arachinonyl-sn-glycerol), and DOG (1,2-dioctanoyl-sn-glycerol) (TRPV1); [42,43] for13-HODE, 13-oxo-HODE, 9-HODE and
9-oxo-HODE (TRPV1); [60] for NADA and OLDA (TRPV1); [59] for OAG, (TRPV1); [61] for LPC (TRPV2); [62] for cannabinoids CB (TRPV2).
1820 F.J. Taberner et al. / Biochimica et Biophysica Acta 1848 (2015) 1818–1827of arachidonic acid by PLA2 and generation of 12-(S)HPETE [36,68]. LOX
also produces 9-HODE and 13-HODE from linoleic acid [42,43]. HODEs
selectively act on TRPV1. This cascade seems to be initiated by noxious
heat and contributes to heat sensitivity. Since HODEs are released
during cell injury, their production could represent a mechanism for
inﬂammatory hyperalgesia and mechanical allodynia [42,43].
In addition to LOX metabolites, pro-inﬂammatory lipidergic media-
tors that affect TRPV1 activity include prostaglandins [69]. Their effect
is mediated through different intracellular pathways, which culminate
in the phosphorylation of the channel through PKC or PKA [70]. Further-
more, prostaglandins like PGA1, PGA2, 8-iso-PGA2, 15-deoxy-PGJ2 and
D12-PGJ2, formed by non-enzymatic dehydration of the respective PGs
(PGD2, PGE2 and PGE1), are also TRPA1 ligands and directly gate the
channel to cause acute nociception [50,71,72]. Based on the recent
evidence that TRPA1 antagonists alleviate visceral nociception, the
blockade of cyclopentone prostaglandin formation may represent a
novel avenue for therapeutic intervention in inﬂammatory visceral
pain [72]. Other prostaglandins like PGE2 activate GPCRs leading to
TRPV4 channel phosphorylation and activation [73].
CYP-derived endogenous signaling lipids, the epoxyeicosatrienoic
acids (EETs) and epoxymetabolites of arachidonic acid, have also been
identiﬁed to interact with thermosensory TRP channels. Lipids 5,6-EET
and to a lesser extent 8,9-EET have been identiﬁed to directly activate
TRPV4 in vascular endothelial cells, promoting vasorelaxation [74].
Moreover, at high concentrations (N10 μM), 5,6-EET can activate
TRPV4 in colonic afferents where it may cause visceral hyperalgesia
[75,76]. However, in lumbal DRG L4 and L5 neurons, 5,6-EET causes
Ca2+ transients independently of TRPV4 and acts as an endogenous
TRPA1 activator. 5,6-EET is synthesized in dorsal root ganglia and the
dorsal horn of the spinal cord during acute pain and causes mechanical
hypersensitivity by activating TRPA1 on primary afferent terminals in
the L4–L5 section of the dorsal horn [45]. Also, 8,9-EET is able to sensi-
tize AITC-induced TRPA1 responses in DRG-neurons through still
unknown mechanisms [45].Nitrate fatty acids such as 9-nitroleic acid (OA-NO2) that are gener-
ated during inﬂammation by phospholipids and nitric oxide (NO) are
other endogenous lipidergic TRPA1 and TRPV1 activators [54]. The ef-
fect of OA-NO2 on afferent neurons is initially excitatory; however,
prolonged exposure to OA-NO2 may desensitize the TRPV1 and TRPA1
channels and, in turn, suppress nociceptive and inﬂammatory responses
[54]. It has been shown that subcutaneous injection of OA-NO2 into a rat
hindpaw induced delayed and prolonged nociceptive behavior. These
results raise the possibility that OA-NO2 might be useful clinically to re-
duce neurogenic inﬂammation and certain types of painful sensations
by desensitizing TRPA1 expressed in nociceptive afferents [77].
It is interesting that resolvins, the most potent endogenous lipid
ligands described thus far, selectively inhibit the TRPV1 and TRPA1
gating. RvD2 and RvE1 inhibit the capsaicin-activated currents at IC50
values of 0.1 nM and 1 nM concentrations, respectively [47], and AITC-
activated currents with IC50 values of 2 nM and 9 nM, respectively.
These results suggest distinct roles of resolvins in regulating TRP chan-
nels and identify RvD2 as a very potent endogenous inhibitor of
inﬂammatory pain [47].
Another lipid that modulates thermosensory channels is the choles-
terol intermediate lipid farnesyl pyrophosphate (FPP). This lipid is the
sole known endogenous TRPV3 activator and made its effect via direct
channel interaction. FPP has a strong potency and it produces a
hyperalgesic effect in vivo [58]. FPP synthase is inhibited by nitrogen con-
taining biphosphonates, which proved to be useful in certain types of
bone cancer and neuropathic pain [80]. In contrast, RvD1 inhibits periph-
erally expressed TRPV3 leading to a modality-speciﬁc antinociception.
Thus, stimulating the endogenous production of RvD1 or the extraneous
administration of it and even its possible synthetic analogues might help
reverse TRPV3-mediated pain states [53]. Since TRPV3 has been implicat-
ed in inﬂammatory pain [58] and skin disorders [81], manipulation of
TRPV3 activity by FPP synthase blockers or RvD1 may be exploited for
therapeutic purposes. Taken together, TRP channels have broad spectrum
of chemoceptive sensitivity unlike the canonical ligand gated ion
Fig. 2. Lipid metabolites implicated in TRP channel modulation. Abbreviations: Phospholipase C (PLC), phospholipase A (PLA2), iPLA2: Ca2+ insensible, cPLA2: citosolic, cytochrome P450
(CYP), cyclooxygenases (COX), lipoxygenases (LOX), HETEs: hydroxyeicosatetraenoic acids, EETs: epoxyeicosatrienoic acids, OLAMs: oxidized linoleic acid metabolites, leukotriene (LK),
resolvin (Rsv) prostaglandins (PG), N-arachidonoyldopamine (NADA), N-oleoyldopamine (OLDA).
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molecules to signal a wide range of stimuli from physiological to noxious
stimuli.
3. Membrane micro-domains as modulators of TRP channels
One of the most studied membrane micro-domains are lipid rafts
which are domains rich in cholesterol, sphingomyelin and gangliosides
that play an important role modulating the activity of ion channels as
the nicotinic acetylcholine channel [82–86]. A similar central role has
been reported for TRPM8 channels [29], whose activity is critically reg-
ulated by lipid raft association. Menthol- and cold-mediated responses
of TRPM8 were potentiated when the association of the channel with
lipid rafts was prevented. In addition, lipid raft disruption shifted the
threshold for TRPM8 activation to a warmer temperature [29].
Intriguingly, several studies conducted with TRPV1 have provided
controversial results. Depletion of cholesterol, upon incubation with
methyl β-cyclodextrin (MCD), did not change heat activation currents
in TRPV1 expressed in Xenopus laevis oocytes, while in dorsal root
ganglion neurons the amplitude of capsaicin-activated currents was
signiﬁcantly reduced [87]. In contrast, it was reported that 3(H)RTX
binding to TRPV1 receptors was notmodulated by cholesterol depletion
in rat C6 glioma cells [88]. However, disruption of lipid rafts by depleting
any of its cardinal constituents, namely cholesterol, sphingomyelin or
gangliosides by pharmacological tools blocked TRPV1 gating by various
agonists [89]. Inhibition of Ca2+ responses occurred when cholesterol
was depleted by MCD [87,90], or when extracellular sphingomyelin
molecules were broken down by sphingomyelinase [91], and also
when the cells were incubated with D-PDMP or myriocin which reduce
the biosynthesis of gangliosides by inhibiting ceramide glucosylation[92]. However, capsaicin-induced TRPV1 single channel currents in
HEK293-transfected cells were not changed after cholesterol depletion,
but diminished with cholesterol addition. R579D and F758Q substitu-
tions in the S5 helix of TRPV1 reduced this cholesterol inhibitory effect
[93]. Thus, the role of hydrophobic interactions in drug/agonist binding
to the TRP channel/lipid raft interface might be more important in drug
action than it has previously been taken into account [29,89,94].
Apart from lipid rafts, the inﬂuence of other membrane micro-
domains has not been described. Similarly, whether lipidic metabolites
exert part of their modulating TRP activity by creating such micro-
domains in the membrane is yet elusive, but very exciting notion.4. Modulation of TRP channel function by phosphoinositides
The most studied lipid modulator of TRP channel activity is
phosphoinositides, which appear to be a master regulator of this family
of ion channels. The regulatory role of phosphoinositides on ion chan-
nels was ﬁrst demonstrated by the PI(4,5)P2 requirement of the cardiac
KATP channels [95]. Subsequent publications indicated that members of
inwardly-rectifying and voltage-gated K+ and voltage-gated Ca2+
channel families were also regulated by PI(4,5)P2 (see [19,96]). TRP
channels are also subjected to phosphoinositide regulation. This regula-
tion could be by direct binding or by indirect mechanisms involving
interacting proteins whose function depends on PIP2 binding. A good
example of that is the Erzin-PIP2 interaction that strengthens actin
binding to the cellular membrane and modulates cell adhesion and
morphology [97]. Similarly, it has been proposed that the membrane
protein Pirt can modulate TRPV1 activity trough a PIP2-dependent
mechanism [52]. This mode of regulation has not been intensively
Fig. 3. Possible action of PIP2 on TRP channels. PIP2 binding close to the channel pore
allows the interactions of the S4–S5 linker with the TRP domain. Variations of PIP2 levels
regulate channels responsiveness by uncoupling the sensing domains from the channel
gate. The drawing represents a single subunit of the tetramer. The pivotal regions for stim-
uli coupling are named in the picture. The S4–S5 loop (S4–S5)/TRP domain (TRPd) inter-
actions are represented by a green cloud and the PIP2 moiety is colored in purple.
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PIP2-mediated modulators of TRP channels.
The direct effect of PI(4,5)P2 on channel activity has been well
characterized for TRPM8. Menthol-evoked currents in TRPM8 inside-
out patch clamp recordings run down as consequence of the phospha-
tases that eliminate PI(4,5)P2. Similarly, sequestering membrane PIP2
with polylysin or anti-PI(4,5)P2 antibody inactivates the channel [55,
98]. In cells, the inactivation of TRPM8 by the rapamycin-induced 5′
phosphatase or with Ciona intestinalis Voltage Sensitive Phosphatase
(ciVSP) further support that membrane PIP2 depletion inactivates
TRPM8 [99,100]. Conversely, recovering PI(4,5)P2 levels with the
short acyl chain counterpart diC8-PIP2 or by stimulating the conversion
of PI(4)P into PI(4,5)P2withMgATP, recovers the activity of the cold re-
ceptor in excised patches [55,98,100]. In terms of speciﬁcity the ﬁnding
that TRPM8 activity in excised patches or in artiﬁcial bilayers is not sup-
ported by PI(4)P, PI(3,5)P2 or PI(3,4,5) underscores a strict requirement
for PI(4,5)P2 [101,102]. The requirement of PIP2 for channels activity
has also been reported for TRPM4, TRPM5, TRPM6, TRPM7 and TRPV5
[55,103–107].
The scenario reported for TRPV1 is markedly different. In this case
the hydrolysis of PI(4,5)P2 favors channel function by relieving tonic
channel inhibition or by the action of the generated secondmessengers
[24,108,109]. However, recent ﬁndings on TRPV1 underscore that
besides its inhibitory role, PI(4,5)P2 is also a necessary cofactor for
channel activation. PI(4,5)P2 and PI(4)P enhance the activity of TRPV1
[110–113] and its depletion decrease channel activity [25,111,114].
Furthermore, rundown of PIP2 is determinant for desensitization upon
prolonged exposure to an activating stimulus [25,110,115]. At variance
with TRPM8, TRPV1 channel activity can be supported, although at a
lower extent, by PI(4)P, PI(3,4)P2 and PIP(3,4,5)P3 and other phospho-
lipids such as phosphatidylglycerol [26,110]. Negative charged lipids
such as oleolyl-CoA or 1,2-dioleoyl-sn-glycero-3-((N-(5-amino-1-
carboxypentyl)iminodiacetic acid)succinyl) (DGS-NTA) can also
hold TRPV1 function as well, implying a low selectivity of TRPV1 in
phosphoinositide binding [26]. Noteworthy, the dependence of the
TRP channel function on speciﬁc phosphoinositides offers new layers
of regulation. First, it imposes a temporal constrain to the channel
response such that a sustained signal can be easily terminated. And,
second, the different content on phosphoinositides of the subcellular
membranes spatially restricts the channel activity to the speciﬁc
membranes or membrane regions [96].
Virtually any stretch of positive residues can interact with PI(4,5)P2.
Several of such sequences can be found in almost all TRP channels but
not all of them mediate PIP2 regulation. Functionally relevant binding
sites have been characterized by combining molecular biology tech-
niques such as site directed mutagenesis with patch clamp recordings.
In TRPM8, positively charged amino acids in the TRPbox, a 6-mer
conserved domain in the C-terminus near the internal channel
gate, mediate PIP2 effect. When K995, R998 and R1008 are mutated,
the sensitivity for PI(4,5)P2 decreases accompanied with channel
blockade by PIP2 depletion [55]. Mutations in the N-end of the C-
terminus, the so-called TRP domain, also affect the sensitivity for
PIP2 in TRPM5, TRPV1 and TRPV5 [55,116,117]. However, they have
little effect, if any, on TRPM4 suggesting the existence of other PIP2
binding sites for channel modulation. Indeed, TRPM4–PIP2
interacting region is located in the PH-like domain at the distal C-
terminus of the channel [103].
A group of positive residues downstream the TRPbox of TRPV1 and
TRPV2 has been shown to interact with PIP2, implying that it may be
shared by other TRP channels and serve as a general regulatory region
in this family of ion channels [112]. It is also worth mentioning that
not all PIP2 binding sites reside in the C-terminus of the channel.
A case in point is TRPV4 who has the PIP2 biding site in the cytosolic
N-terminus. It has been proposed that PIP2 binding in TRPV4 favors
the conformational rearrangements that lead to the activation of the
channel by hypotonicity and heat [118].Structure–function studies pinpoint to the TRP domain as a pivotal
region for channel gating and PIP2 modulation as it contains residues
central for PIP2 binding [119–122]. The functional relevance of this
domain has been further substantiated by its conformation in the
proposed high resolution TRPV1 structural model [11]. Recent studies
have further demonstrated the importance of the TRP domain on allo-
steric channel activation. Mutations targeting W697 in the TRP box of
TRPV1 resulted in a complete loss of voltage sensitivity while retaining
capsaicin response [121]. Interestingly, the W697 is interacting with
S4–S5 loop considered central for voltage sensing [11,121]. In TRPM8,
mutations Y981E and Y981K destabilized the gate resulting in constitu-
tive channel opening [122]. Interestingly, subsequent mutations on
the S6-TRP box linker restored the regulated activity mainly by re-
establishing coupling of stimuli sensing and pore opening. Mutations
in the TRP domainwith greater functional impact reside at the predicted
interaction interface between the TRP helix and the loop S4–S5 [122],
suggesting that the TRP helix/S4–S5 loop interaction is central for trans-
mitting different stimuli to the gate. Remarkably, these regions have
also intense PIP2 contacts with residues in the S4–S5 loop such as
those suggested for TRPV1 [116,117]. Thus, PIP2 binding can strengthen
the TRP helix/S4–S5 loop interaction favoring coupling of the putative
voltage sensor and the channel pore. Noteworthy, S4–S5 loop/PIP2 con-
tacts have been shown to control the pore opening in Kv channels [123].
Taking together, it is tempting to propose that by tethering the TRP
domain to the membrane, PIP2 promotes and strengthens the TRP
helix/S4–S5 loop interaction setting the structural framework for the
allosteric regulation of channel gating (Fig. 3).
5. TRP channels contain putative lipid binding sites
A central question arises: are there binding sites for lipids in TRP
channels? Can the channel structure reveal speciﬁc lipid docking
sites? Although it has been reported that lipids modulated the channel
activity of TRP channels, there is no information regarding the presence
of lipid binding sites in the receptor. This limitation likely arises from
Fig. 4. TRPV1 in complex with lipids transferred from Kv1.2/Kv2.1 potassium channel. A. Extracellular view of the TRPV1 showing annular and non-annular lipids. Protein chains are
represented in ribbon and color blue, red, yellow and magenta. Lipids in ball representation, with carbon and oxygen colored cyan and red, respectively. B. Side view of TRPV1 showing
the transmembrane α-helices and the inner and outer membrane leaﬂets. C. Detail of non-annular lipid involved in intrasubunit interactions, putatively assigned to PIP2 binding site.
D. Detail of other non-annular lipids in the inner and outer membrane leaﬂets.
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which is restricted to the cytosolic ankyrin domains and peptides from
the C-terminal. TheAnkyrin-repeat domain (ARD) from the cytoplasmic
N-terminus of different TRP channels has been characterized by X-ray
crystallography unraveling binding sites for regulatory molecules
[124–128]. At variance, obtaining structures for the full-length channel
is cumbersome as these proteins are hard to crystallize and the crystals
diffract poorly. Alternatively, electron cryo-microscopy structures of
full-length TRPV1, TRPV2, TRPV4 and TRPA1 have disclosed the molec-
ular architecture and subunit organization [127,129–131], although at
a low resolution (13.6 Å at most). Recently, however, a breakthrough
in TRP channel structure was reached. Using single particle electron
cryo-microscopy, a 3.4 Å structural model of TRPV1 lacking the distal
part of the C-terminus was reported for the closed and open states
[11,132]. Unfortunately, none of these structures were determined in
complex with lipids.
Thus, to uncover putative lipid binding sites on TRP channels, we
used the structural information available for other ion channels.
Hence, we superposed the TRPV1 EM structural model on representa-
tive Kv, Nav and Cav ion channels structures obtained in complex with
lipids. Then, the lipids were transferred to the TRPV1 structural model
to determine whether the TRP channel exhibited similar binding sites.
Small clashes between lipid fragments and TRPV1 residues were
removed by molecular steepest descent minimization.
Fig. 4 shows different views of the TRPV1 channel with lipids trans-
ferred from the Kv1.2/Kv2.1 (paddle-chimera) Kv channel (code 2R9R)
[133]. A top view of TRPV1 in complex with transferred lipids (Fig. 4A)
shows a similar arrangement of annular and non-annular lipid around
the channel, denser in the outer leaﬂet (Fig. 4B). Annular lipids ﬁt well
on TRPV1 in both leaﬂets. In the inner leaﬂet two phospholipidergic
fragments are in deep contact with the S4–S5 linker (Fig. 4C), a region
of the channel that couples voltage-sensor domain and the pore
for channel gating [134–136]. TRPV1 conformation is compatible
with two phospholipids, one is in deep intrasubunit contacts with the
S4–S5 linker (Fig. 4C, left), the TRP domain and the S1–S4 domain. The
other interaction is mediated by inter-subunit contacts with S5 and
the beginning of S4–S5 linker (Fig. 4C, right). The polar head group ofboth phospholipids resides at different depths in the membrane,
which has been related to the perturbation that protein exerts on the
membrane at lipid–protein interface [133]. This unusual position for a
phospholipid is related to speciﬁc favorable contacts with the protein,
probably inﬂuencing its structure and function [137].
PIP2 has been described as a special case since it modulates the
activity of many types of ion channels in a variety of modes [31–33],
including TRPV1 [116,117]. The current understanding of the structural
requirements for PIP2 binding comes from potassium inward rectifying
channels. The crystal structure of Kir2.2 shows that the phosphoinositide
binds at the interface between the transmembrane domain and the C-
terminal domain. A closer look at the binding site discloses hints for
PIP2 interaction: the acyl chains are accommodated by hydrophobic sur-
faces of the transmembrane region and the negative charged phosphate
interact with positively R and K residues in tether helix [138]. Brauchi
et al. [116] hypothesized that the polar head group of PIP2 could contact
with the TRP domain through basic residues (R701 and K710), and the
acyl chain could mediate the interaction between two adjacent subunits.
In the model, the location of the PIP2 head group is compatible with the
interaction with R701 (and probably with K710) in the TRP domain, and
with R575 in the S4–S5 linker.
Fig. 5 depicts TRPV1 channel in complexwith lipids transferred from
a Cav ion channel (code 4MS2). Non-annular lipids also ﬁt well on
TRPV1 intersubunit spaces, as observed for lipids transferred from Kv
channels (Fig. 4). A detailed view of the outer leaﬂet indicates that
non-annular lipids occupy three kinds of intersubunit grooves, includ-
ing regions between S1–S4 (blue chain) and pore (red chain), interpore
(red and blue chains), and between pore (blue chain) and the S1–S4
(magenta chain) domains (Fig. 5C). Polar head groups appear to interact
with proximal basic residues such as K535, K603, K656, and R534,while
acyl chains appear to occupy hydrophobic clefts at the transmembrane
level. Themost noticeable feature of the TRPV1 in complexwith lipids is
that TRPV1 conformation is also compatible with lateral pore fenestra-
tions observed for Nav and Cav channels [139–141]. These lateral
portals revealed a hydrophobic access pathway to the central cavity
(Fig. 5D), which could explain the effect observed for some general
and local anesthetics, which has been shown to activate different TRP
Fig. 5. TRPV1 in complex with lipids transferred from a Cav channel. A. Extracellular view of the TRPV1 showing lipids derived from the crystal (code 4MS2). Representation similar with
Fig. 4. B. Side view of TRPV1 showing the transmembraneα-helices and the lipids fragments, mainly located in the outer leaﬂets. C. Detail of annular lipid involved in intersubunit inter-
actions in hydrophobic clefts of three protein subunits (blue, red andmagenta). D. Detail of the hydrophobic portals connecting themembrane and the central pore cavity, as observed for
closed Nav and Cav channels.
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channels has been related to the different-sized drugs or hydrophobic
molecules gaining access to the central cavity during different stages
of pore gating [140]. In the case of TRPV1, superposition with Cav and
Nav channels denoted a shorter cavity (4 × 4 Å in TRPV1 vs 8 × 10 Å
in Nav) due to a displacement of the selectivity ﬁlter and pore-helix
that reduces the portal entrance to the inner cavity. Consequently, this
lipid binding site could be restricted in TRPV1 to acyl chain-like mole-
cules rather than to di-acylated molecules such as phospholipids, or
other higher size hydrophobic molecules. Furthermore, the portal
entering is very close to the vanilloid binding site, as described for cap-
saicin and resiniferatoxin in TRPV1 [132]. In addition, the intersubunit
region connecting S5 from one subunit and the beginning of S4–S5
from the adjacent subunit is compatible with the proposed docking-
generated model for cholesterol binding [28], since transference of
lipids to TRPV1 locates phospholipids (Fig. 4C) or acyl chains in this
position. Taken together, these observations indicate that, at least in
TRPV1 channels, there are well-deﬁned binding sites for lipids, suggest-
ing a critical role of these molecules in TRPV1 gating. In addition, the
modeled structures indicate that TRPV1 channels may accommodate a
variety for lipid molecules, thus augmenting the modulatory mecha-
nisms of channel gating. These observations for TRPV1 may be also
extended to other TRP channels, as the transmembrane region is quite
conserved within the TRP channel superfamily.
6. Outlook
Sensory TRP ion channels are crucial molecular components of pain
transduction. Identiﬁcation of their natural ligands has provided
insights into the molecular basis of peripheral pain. Coincidently,
lipid-derived substances are emerging as important biological media-
tors. The diversity of endogenous lipids as modulators for sensory
TRP-channels demonstrates the complexity of lipid signaling in noci-
ceptive processing. Studies on the modulation of TRP channel function
by lipidergic endogenous agents have contributed to our understandingof the interaction between sensory nerves and diseased or damaged
tissues, which is central in the generation and maintenance of pain.
However, there are still many unsolved issues. Matching clinical pain
types with TRP subtypes remains a challenge, particularly outside of
TRPV1. For example, the role of TRPV2, a noxious heat receptor, to
pain generation remains elusive. Its lipid interaction is also unclear. In
addition, better information on the ligand binding site (amino acids) is
needed to establish the pharmacological rationale for optimizing
synthetic therapeutic agents targeting TRPs. Future studies are needed
to systematically identify the physiological role for each lipid group in
pain perception by lipidomic approaches.
Unveiling the lipidergic structures that modulate TRP function may
allow for novel lead compound synthesis for analgesics aimed at TRPs.
As lipids participate in other biological phenomena including inﬂamma-
tion, it is possible to pursue the development of multi-target drugs. De-
pending on TRP expressing sites and their differential functionalities,
other beneﬁcial effects in different disciplines such as dermatology or
cardiovascular physiology can be also envisioned. The advantage of
using potent lipid modulators of TRPs, such as resolvins, for the treat-
ment of inﬂammatory pain over conventional NSAIDs is that they can
resolve inﬂammation and pain by restoring cellular/tissue homeostasis
using endogenous signaling pathways. Collectively, an expansion of our
knowledge on lipidergic ligands and themolecular nature of their inter-
actions with sensory TRP channels will improve our understanding of
peripheral pain mechanisms and contribute to clinical intervention for
associated diseases.
Conﬂict of interest
The authors declare no conﬂict of interest.
Transparency document
The Transparency document associated with this article can be
found, in the online version.
1825F.J. Taberner et al. / Biochimica et Biophysica Acta 1848 (2015) 1818–1827Acknowledgments
Thiswork has been supported by grants from the SpanishMinisterio
de Economía y Competitividad (MINECO) (BFU2012-39092-C02-01) to
AFMand, the CONSOLIDER-INGENIO 2010 Program (CSD2008-00005 to
AFM), and the Generalitat Valenciana PROMETEO/2014/011 and ISIC/
2012/009 to AFM.References
[1] D.E. Clapham, L.W. Runnels, C. Strübing, The trp ion channel family, Nat. Rev.
Neurosci. 2 (2001) 387–396.
[2] D.E. Clapham, TRP channels as cellular sensors, Nature 426 (2003) 517–524.
[3] K. Venkatachalam, C. Montell, TRP channels, Annu. Rev. Biochem. 76 (2007)
387–417.
[4] V. Flockerzi, B. Nilius, TRPs: Truly Remarkable Proteins, in: B. Nilius, V. Flockerzi
(Eds.),Mammalian Transient Receptor Potential (TRP) Cation Channels, vol. 222,
Springer, Berlin, Heidelberg 2014, pp. 1–12.
[5] A.I. Basbaum, D.M. Bautista, G. Scherrer, D. Julius, Cellular and molecular mecha-
nisms of pain, Cell 139 (2009) 267–284.
[6] D. Julius, TRP channels and pain, Annu. Rev. Cell Dev. Biol. 29 (2013) 355–384.
[7] R. Vennekens, A. Menigoz, B. Nilius, TRPs in the Brain, in: B. Nilius, S.G. Amara, T.
Gudermann, R. Jahn, R. Lill, S. Offermanns, O.H. Petersen (Eds.),Reviews of Physiol-
ogy, Biochemistry and Pharmacology, vol. 163, Springer, Berlin, Heidelberg 2012,
pp. 27–64.
[8] M.B. Morelli, C. Amantini, S. Liberati, M. Santoni, M. Nabissi, TRP channels: new
potential therapeutic approaches in CNS neuropathies, CNS Neurol. Disord. Drug
Targets 12 (2013) 274–293.
[9] E. Fernandes, M. Fernandes, J. Keeble, The functions of TRPA1 and TRPV1: moving
away from sensory nerves: TRPA1 and TRPV1: moving away from sensory nerves,
Br. J. Pharmacol. 166 (2012) 510–521.
[10] B. Nilius, TRP channels in disease, Biochim. Biophys. Acta (BBA) — Mol. Basis Dis.
1772 (2007) 805–812.
[11] M. Liao, E. Cao, D. Julius, Y. Cheng, Structure of the TRPV1 ion channel determined
by electron cryo-microscopy, Nature 504 (2013) 107–112.
[12] A. Ferrer-Montiel, A. Fernandez-Carvajal, R. Planells-Cases, G. Fernandez-Ballester,
J.M. Gonzalez-Ros, A. Messeguer, R. Gonzalez-Muniz, Advances in modulating
thermosensory TRP channels, Expert Opin. Ther. Pat. 22 (2012) 999–1017.
[13] A. Fernandez-Carvajal, G. Fernandez-Ballester, I. Devesa, J.M. Gonzalez-Ros, A.
Ferrer-Montiel, New strategies to develop novel pain therapies: addressing
thermoreceptors from different points of view, Pharmaceuticals 5 (2011) 16–48.
[14] I. Devesa, R. Planells-Cases, G. Fernandez-Ballester, J.M. Gonzalez-Ros, A. Ferrer-
Montiel, A. Fernandez-Carvajal, Role of the transient receptor potential vanilloid
1 in inﬂammation and sepsis, J. Inﬂamm. Res. 4 (2011) 67–81.
[15] K. Talavera, B. Nilius, T. Voets, Neuronal TRP channels: thermometers, pathﬁnders
and life-savers, Trends Neurosci. 31 (2008) 287–295.
[16] R. Strotmann, C. Harteneck, K. Nunnenmacher, G. Schultz, T.D. Plant, OTRPC4, a
nonselective cation channel that confers sensitivity to extracellular osmolarity,
Nat. Cell Biol. 2 (2000) 695–702.
[17] C.Moore, F. Cevikbas, H.A. Pasolli, Y. Chen,W. Kong, C. Kempkes, P. Parekh, S.H. Lee,
N.-A. Kontchou, I. Yeh, N.M. Jokerst, E. Fuchs, M. Steinhoff, W.B. Liedtke, UVB
radiation generates sunburn pain and affects skin by activating epidermal TRPV4
ion channels and triggering endothelin-1 signaling, Proc. Natl. Acad. Sci. 110 (2013)
E3225–E3234.
[18] D. Julius, J. Nathans, Signaling by Sensory Receptors, Cold Spring Harb. Perspect.
Biol. 4 (2012) (a005991-a005991).
[19] T. Rohacs, Phosphoinositide Regulation of TRP Channels, in: B. Nilius, V. Flockerzi
(Eds.),Mammalian Transient Receptor Potential (TRP) Cation Channels, vol. 223,
Springer International Publishing, Cham 2014, pp. 1143–1176.
[20] M. Sisignano, D.L.H. Bennett, G. Geisslinger, K. Scholich, TRP-channels as key inte-
grators of lipid pathways innociceptive neurons, Prog. LipidRes. 53 (2014) 93–107.
[21] S. Yoo, J. Lim, S. Hwang, Sensory TRP channel interactions with endogenous lipids
and their biological outcomes, Molecules 19 (2014) 4708–4744.
[22] Y. Yu, C.R.J. Carter, N. Youssef, J.R.B. Dyck, P.E. Light, Intracellular long-chain acyl
CoAs activate TRPV1 channels, PLoS One 9 (2014) e96597.
[23] S.-I. Choi, S. Yoo, J. Lim, S. Hwang, Are sensory TRP channels biological alarms for
lipid peroxidation? Int. J. Mol. Sci. 15 (2014) 16430–16457.
[24] E. Cao, J.F. Cordero-Morales, B. Liu, F. Qin, D. Julius, TRPV1 channels are intrinsically
heat sensitive and negatively regulated by phosphoinositide lipids, Neuron 77
(2013) 667–679.
[25] V. Lukacs, Y. Yudin, G.R. Hammond, E. Sharma, K. Fukami, T. Rohacs, Distinctive
changes in plasma membrane phosphoinositides underlie differential regulation
of TRPV1 in nociceptive neurons, J. Neurosci. 33 (2013) 11451–11463.
[26] V. Lukacs, J.M. Rives, X. Sun, E. Zakharian, T. Rohacs, Promiscuous activation of
transient receptor potential vanilloid 1 (TRPV1) channels by negatively charged
intracellular lipids: the key role of endogenous phosphoinositides in maintaining
channel activity, J. Biol. Chem. 288 (2013) 35003–35013.
[27] S.L. Morales-Lazaro, B. Serrano-Flores, I. Llorente, E. Hernandez-Garcia, R.
Gonzalez-Ramirez, S. Banerjee, D. Miller, V. Gududuru, J. Fells, D. Norman, G.
Tigyi, D. Escalante-Alcalde, T. Rosenbaum, Structural determinants of the transient
receptor potential 1 (TRPV1) channel activation by phospholipid analogs, J. Biol.
Chem. 289 (2014) 24079–24090.[28] S.L. Morales-Lazaro, S.A. Simon, T. Rosenbaum, The role of endogenous molecules
in modulating pain through transient receptor potential vanilloid 1 (TRPV1), J.
Physiol. 591 (2013) 3109–3121.
[29] C. Morenilla-Palao, M. Pertusa, V. Meseguer, H. Cabedo, F. Viana, Lipid raft segrega-
tion modulates TRPM8 channel activity, J. Biol. Chem. 284 (2009) 9215–9224.
[30] A.M. Dopico, A.N. Bukiya, A.K. Singh, Large conductance, calcium- and voltage-
gated potassium (BK) channels: regulation by cholesterol, Pharmacol. Ther. 135
(2012) 133–150.
[31] T. Balla, Phosphoinositides: tiny lipids with giant impact on cell regulation, Physiol.
Rev. 93 (2013) 1019–1137.
[32] F.S. Choveau, F. Abderemane-Ali, F.C. Coyan, Z. Es-Salah-Lamoureux, I. Baro, G.
Loussouarn, Opposite effects of the S4–S5 Linker and PIP(2) on voltage-gated
channel function: KCNQ1/KCNE1 and other channels, Front. Pharmacol. 3
(2012) 125.
[33] D.W. Hilgemann, S. Feng, C. Nasuhoglu, The complex and intriguing lives of PIP2
with ion channels and transporters, Sci. STKE 2001 (2001) re19.
[34] S. Chyb, P. Raghu, R.C. Hardie, Polyunsaturated fatty acids activate the Drosophila
light-sensitive channels TRP and TRPL, Nature 397 (1999) 255–259.
[35] P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sorgard, M.V. Di, D.
Julius, E.D. Hogestatt, Vanilloid receptors on sensory nervesmediate the vasodilator
action of anandamide, Nature 400 (1999) 452–457.
[36] S.W. Hwang, H. Cho, J. Kwak, S.Y. Lee, C.J. Kang, J. Jung, S. Cho, K.H. Min, Y.G. Suh, D.
Kim, U. Oh, Direct activation of capsaicin receptors by products of lipoxygenases:
endogenous capsaicin-like substances, Proc. Natl. Acad. Sci. U. S. A. 97 (2000)
6155–6160.
[37] A. Szallasi, P.M. Blumberg, Complex Regulation of TRPV1 by Vanilloids, 2007.
[38] S.M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, P.L. De, F. Fezza, M. Tognetto, T.J.
Petros, J.F. Krey, C.J. Chu, J.D. Miller, S.N. Davies, P. Geppetti, J.M. Walker, M.V. Di,
An endogenous capsaicin-like substance with high potency at recombinant and
native vanilloid VR1 receptors 127, Proc. Natl. Acad. Sci. U. S. A. 99 (2002)
8400–8405.
[39] P.L. De, M.V. Di, Lipids as regulators of the activity of transient receptor potential
type V1 (TRPV1) channels, Life Sci. 77 (2005) 1651–1666.
[40] S. Bang, S. Yoo, U. Oh, S.W. Hwang, Endogenous lipid-derived ligands for sensory
TRP ion channels and their pain modulation, Arch. Pharm. Res. 33 (2010)
1509–1520.
[41] A.M. Gregus, S. Doolen, D.S. Dumlao, M.W. Buczynski, T. Takasusuki, B.L.
Fitzsimmons, X.Y. Hua, B.K. Taylor, E.A. Dennis, T.L. Yaksh, Spinal 12-lipoxygenase-
derived hepoxilin A3 contributes to inﬂammatory hyperalgesia via activation of
TRPV1 and TRPA1 receptors, Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 6721–6726.
[42] A.M. Patwardhan, A.N. Akopian, N.B. Ruparel, A. Diogenes, S.T. Weintraub, C.
Uhlson, R.C. Murphy, K.M. Hargreaves, Heat generates oxidized linoleic acid
metabolites that activate TRPV1 and produce pain in rodents, J. Clin. Invest. 120
(2010) 1617–1626.
[43] A.M. Patwardhan, P.E. Scotland, A.N. Akopian, K.M. Hargreaves, Activation of TRPV1
in the spinal cord by oxidized linoleic acidmetabolites contributes to inﬂammatory
hyperalgesia, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 18820–18824.
[44] H. Wen, J. Ostman, K.J. Bubb, C. Panayiotou, J.V. Priestley, M.D. Baker, A.
Ahluwalia, 20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of
transient receptor potential vanilloid 1 (TRPV1) channel, J. Biol. Chem. 287
(2012) 13868–13876.
[45] M. Sisignano, C.K. Park, C. Angioni, D.D. Zhang, C. von H., E.J. Cobos, N. Ghasemlou,
Z.Z. Xu, V. Kumaran, R. Lu, A. Grant, M.J. Fischer, A. Schmidtko, P. Reeh, R.R. Ji, C.J.
Woolf, G. Geisslinger, K. Scholich, C. Brenneis, 5,6-EET is released upon neuronal
activity and inducesmechanical pain hypersensitivity via TRPA1 on central afferent
terminals, J. Neurosci. 32 (2012) 6364–6372.
[46] A. Nieto-Posadas, G. Picazo-Juarez, I. Llorente, A. Jara-Oseguera, S. Morales-Lazaro,
D. Escalante-Alcalde, L.D. Islas, T. Rosenbaum, Lysophosphatidic acid directly acti-
vates TRPV1 through a C-terminal binding site 108, Nat. Chem. Biol. 8 (2012)
78–85.
[47] C.K. Park, Z.Z. Xu, T. Liu, N. Lu, C.N. Serhan, R.R. Ji, Resolvin D2 is a potent endoge-
nous inhibitor for transient receptor potential subtype V1/A1, inﬂammatory pain,
and spinal cord synaptic plasticity in mice: distinct roles of Resolvin D1, D2, and
E1, J. Neurosci. 31 (2011) 18433–18438.
[48] M. Bandell, G.M. Story, S.W. Hwang, V. Viswanath, S.R. Eid, M.J. Petrus, T.J. Earley, A.
Patapoutian, Noxious cold ion channel TRPA1 is activated by pungent compounds
and bradykinin, Neuron 41 (2004) 849–857.
[49] S. Materazzi, R. Nassini, E. Andre, B. Campi, S. Amadesi, M. Trevisani, N.W. Bunnett,
R. Patacchini, P. Geppetti, Cox-dependent fatty acidmetabolites cause pain through
activation of the irritant receptor TRPA1, Proc. Natl. Acad. Sci. U. S. A. 105 (2008)
12045–12050.
[50] T.E. Taylor-Clark, S. Ghatta, W. Bettner, B.J. Undem, Nitrooleic acid, an endogenous
product of nitrative stress, activates nociceptive sensory nerves via the direct
activation of TRPA1, Mol. Pharmacol. 75 (2009) 820–829.
[51] Y. Dai, S. Wang, M. Tominaga, S. Yamamoto, T. Fukuoka, T. Higashi, K. Kobayashi, K.
Obata, H. Yamanaka, K. Noguchi, Sensitization of TRPA1 by PAR2 contributes to the
sensation of inﬂammatory pain, J. Clin. Invest. 117 (2007) 1979–1987.
[52] A.Y. Kim, Z. Tang, Q. Liu, K.N. Patel, D. Maag, Y. Geng, X. Dong, Pirt, a
phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1,
Cell 133 (2008) 475–485.
[53] S. Bang, S. Yoo, T.J. Yang, H. Cho, Y.G. Kim, S.W. Hwang, Resolvin D1 attenuates
activation of sensory transient receptor potential channels leading to multiple
anti-nociception, Br. J. Pharmacol. 161 (2010) 707–720.
[54] A. Sculptoreanu, F.A. Kullmann, D.E. Artim, F.A. Bazley, F. Schopfer, S. Woodcock,
B.A. Freeman, W.C. de Groat, Nitro-oleic acid inhibits ﬁring and activates T, J.
Pharmacol. Exp. Ther. 333 (2010) 883–895.
1826 F.J. Taberner et al. / Biochimica et Biophysica Acta 1848 (2015) 1818–1827[55] T. Rohács, C.M.B. Lopes, I. Michailidis, D.E. Logothetis, PI(4,5)P2 regulates the
activation and desensitization of TRPM8 channels through the TRP domain, Nat.
Neurosci. 8 (2005) 626–634.
[56] D.A. Andersson, M. Nash, S. Bevan, Modulation of the cold-activated channel
TRPM8 by lysophospholipids and polyunsaturated fatty acids, J. Neurosci. 27
(2007) 3347–3355.
[57] H. Watanabe, J. Vriens, J. Prenen, G. Droogmans, T. Voets, B. Nilius, Anandamide
and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels,
Nature 424 (2003) 434–438.
[58] S. Bang, S. Yoo, T.J. Yang, H. Cho, S.W. Hwang, Farnesyl pyrophosphate is a novel
pain-producing molecule via speciﬁc activation of TRPV3, J. Biol. Chem. 285
(2010) 19362–19371.
[59] D.H. Woo, S.J. Jung, M.H. Zhu, C.K. Park, Y.H. Kim, S.B. Oh, C.J. Lee, Direct activation
of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG), Mol.
Pain 4 (2008) 42.
[60] C.J. Chu, S.M. Huang, P.L. De, T. Bisogno, S.A. Ewing, J.D. Miller, R.E. Zipkin, N.
Daddario, G. Appendino, M.V. Di, J.M. Walker, N-oleoyldopamine, a novel endoge-
nous capsaicin-like lipid that produces hyperalgesia 121, J. Biol. Chem. 278 (2003)
13633–13639.
[61] A. Fallah, R. Pierre, E. Abed, R. Moreau, Lysophosphatidylcholine-induced cytotox-
icity in osteoblast-like MG-63 cells: involvement of transient receptor potential
vanilloid 2 (TRPV2) channels, Mol. Membr. Biol. 30 (2013) 315–326.
[62] L. De Petrocellis, A. Ligresti, A.S. Moriello, M. Allara, T. Bisogno, S. Petrosino, C.G.
Stott, V. Di Marzo, Effects of cannabinoids and cannabinoid-enriched Cannabis
extracts onTRP channels andendocannabinoidmetabolic enzymes, Br. J. Pharmacol.
163 (2011) 1479–1494.
[63] C.M. Flores, M.R. Vasko, The deorphanization of TRPV1 and the emergence of
octadecadienoids as a new class of lipid transmitters, Mol. Interv. 10 (2010)
137–140.
[64] N. Qin, M.P. Neeper, Y. Liu, T.L. Hutchinson, M.L. Lubin, C.M. Flores, TRPV2 is activated
by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion
neurons, J. Neurosci. 28 (2008) 6231–6238.
[65] E. Hernandez-Garcia, T. Rosenbaum, Lipidmodulation of thermal transient receptor
potential channels, Curr. Top. Membr. 74 (2014) 135–180.
[66] F. Vanden Abeele, A. Zholos, G. Bidaux, Y. Shuba, S. Thebault, B. Beck, M.
Flourakis, Y. Panchin, R. Skryma, N. Prevarskaya, Ca2 + -independent phos-
pholipase A2-dependent gating of TRPM8 by lysophospholipids, J. Biol. Chem.
281 (2006) 40174–40182.
[67] M. Monet, D. Gkika, V. Lehen'kyi, A. Pourtier, F. Vanden Abeele, G. Bidaux, V. Juvin,
F. Rassendren, S. Humez, N. Prevarsakaya, Lysophospholipids stimulate prostate
cancer cell migration via TRPV2 channel activation, Biochim. Biophys. Acta 1793
(2009) 528–539.
[68] S. Yoo, S. Han, Y.S. Park, J.H. Lee, U. Oh, S.W. Hwang, Lipoxygenase inhibitors
suppressed carrageenan-induced Fos-expression and inﬂammatorypain responses
in the rat, Mol. Cells 27 (2009) 417–422.
[69] J.C. Lopshire, G.D. Nicol, The cAMP transduction cascade mediates the prostaglan-
din E2 enhancement of the capsaicin-elicited current in rat sensory neurons:
whole-cell and single-channel studies, J. Neurosci. 18 (1998) 6081–6092.
[70] K. Mizumura, T. Sugiura, K. Katanosaka, R.K. Banik, Y. Kozaki, Excitation and sensi-
tization of nociceptors by bradykinin: what do we know? Exp. Brain Res. 196
(2009) 53–65.
[71] T.E. Taylor-Clark, B.J. Undem, D.W. Macglashan Jr., S. Ghatta, M.J. Carr, M.A.
McAlexander, Prostaglandin-induced activation of nociceptive neurons via direct
interaction with transient receptor potential A1 (TRPA1), Mol. Pharmacol. 73
(2008) 274–281.
[72] L.M. Pereira, R.C. Lima-Junior, A.X. Bem, C.G. Teixeira, L.S. Grassi, R.P. Medeiros, R.D.
Marques-Neto, R.B. Callado, K.S. Aragao, D.V. Wong, M.L. Vale, G.A. Brito, R.A.
Ribeiro, Blockade of TRPA1 with HC-030031 attenuates visceral nociception by a
mechanism independent of inﬂammatory resident cells, nitric oxide and the opioid
system, Eur. J. Pain 17 (2013) 223–233.
[73] T. Moriyama, T. Higashi, K. Togashi, T. Iida, E. Segi, Y. Sugimoto, T. Tominaga, S.
Narumiya, M. Tominaga, Sensitization of TRPV1 by EP1 and IP reveals peripheral
nociceptive mechanism of prostaglandins, Mol. Pain 1 (2005) 3.
[74] A.A. Spector, Arachidonic acid cytochrome P450 epoxygenase pathway, J. Lipid Res.
50 (2009) S52–S56 (Suppl.).
[75] S.M. Brierley, A.J. Page, P.A. Hughes, B. Adam, T. Liebregts, N.J. Cooper, G. Holtmann,
W. Liedtke, L.A. Blackshaw, Selective role for TRPV4 ion channels in visceral sensory
pathways, Gastroenterology 134 (2008) 2059–2069.
[76] W.E. Sipe, S.M. Brierley, C.M. Martin, B.D. Phillis, F.B. Cruz, E.F. Grady, W. Liedtke,
D.M. Cohen, S. Vanner, L.A. Blackshaw, N.W. Bunnett, Transient receptor potential
vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic
afferent nerves and visceral hyperalgesia, Am. J. Physiol. Gastrointest. Liver Physiol.
294 (2008) G1288–G1298.
[77] X. Zhang, K.B. Koronowski, L. Li, B.A. Freeman, S.Woodcock,W.C. de Groat, Nitro-oleic
acid desensitizes TRPA1 and TRPV1 agonist responses in adult rat DRG neurons, Exp.
Neurol. 251 (2014) 12–21.
[80] R. von M., F. Strasser, S. Gillessen, K. Zaugg, Metastatic bone pain: treatment
options with an emphasis on bisphosphonates, Support. Care Cancer 16 (2008)
1105–1115.
[81] K. Imura, T. Yoshioka, T. Hirasawa, T. Sakata, Role of TRPV3 in immune response to
development of dermatitis, J. Inﬂamm. (Lond.) 6 (2009) 17.
[82] J. Corbin, H.H. Wang, M.P. Blanton, Identifying the cholesterol binding domain in
the nicotinic acetylcholine receptor with [125I]azido-cholesterol, Biochim.
Biophys. Acta 1414 (1998) 65–74.
[83] K. Simons, D. Toomre, Lipid rafts and signal transduction, Nat. Rev. Mol. Cell Biol. 1
(2000) 31–39.[84] S. Mishra, P.G. Joshi, Lipid raft heterogeneity: an enigma, J. Neurochem. 103 (Suppl.
1) (2007) 135–142.
[85] F.J. Barrantes, Cholesterol effects on nicotinic acetylcholine receptor, J. Neurochem.
103 (Suppl. 1) (2007) 72–80.
[86] B. Sjogren, P. Svenningsson, Caveolin-1 affects serotonin binding and cell surface
levels of human 5-HT7(a) receptors, FEBS Lett. 581 (2007) 5115–5121.
[87] M. Liu, W. Huang, D. Wu, J.V. Priestley, TRPV1, but not P2X, requires cholesterol for
its function and membrane expression in rat nociceptors, Eur. J. Neurol. 24 (2006)
1–6.
[88] M. Bari, A. Paradisi, N. Pasquariello, M. Maccarrone, Cholesterol-dependent modu-
lation of type 1 cannabinoid receptors in nerve cells, J. Neurosci. Res. 81 (2005)
275–283.
[89] E. Szoke, R. Borzsei, D.M. Toth, O. Lengl, Z. Helyes, Z. Sandor, J. Szolcsanyi, Effect of
lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons
and transfected cell line, Eur. J. Pharmacol. 628 (2010) 67–74.
[90] E.P. Kilsdonk, P.G. Yancey, G.W. Stoudt, F.W. Bangerter, W.J. Johnson, M.C. Phillips,
G.H. Rothblat, Cellular cholesterol efﬂux mediated by cyclodextrins, J. Biol. Chem.
270 (1995) 17250–17256.
[91] T. Kobayashi, M. Takahashi, Y. Nagatsuka, Y. Hirabayashi, Lipid rafts: new tools and
a new component, Biol. Pharm. Bull. 29 (2006) 1526–1531.
[92] P. Santha, O. Oszlacs, M. Dux, I. Dobos, G. Jancso, Inhibition of glucosylceramide
synthase reversibly decreases the capsaicin-induced activation and TRPV1 expres-
sion of cultured dorsal root ganglion neurons, Pain 150 (2010) 103–112.
[93] G. Picazo-Juarez, S. Romero-Suarez, A. Nieto-Posadas, I. Llorente, A. Jara-Oseguera,
M. Briggs, T.J. McIntosh, S.A. Simon, E. Ladron-de-Guevara, L.D. Islas, T. Rosenbaum,
Identiﬁcation of a binding motif in the S5 helix that confers cholesterol sensitivity
to the TRPV1 ion channel, J. Biol. Chem. 286 (2011) 24966–24976.
[94] Z. Torok, T. Crul, B. Maresca, G.J. Schutz, F. Viana, L. Dindia, S. Piotto, M.
Brameshuber, G. Balogh, M. Peter, A. Porta, A. Trapani, I. Gombos, A. Glatz, B.
Gungor, B. Peksel, L. Vigh Jr., B. Csoboz, I. Horvath, M.M. Vijayan, P.L. Hooper, J.L.
Harwood, L. Vigh, Plasma membranes as heat stress sensors: from lipid-
controlled molecular switches to therapeutic applications, Biochim. Biophys. Acta
1838 (2014) 1594–1618.
[95] D.W. Hilgemann, R. Ball, Regulation of Cardiac Na+, Ca2+ Exchange and KATP
Potassium Channels by PIP2, Science 273 (1996) 956–959.
[96] B. Hille, E.J. Dickson, M. Kruse, O. Vivas, B.-C. Suh, Phosphoinositides regulate ion
channels, Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1851 (2014) 844–856.
[97] J.A. Braunger, B.R. Bruckner, S. Nehls, A. Pietuch, V. Gerke, I. Mey, A. Janshoff, C.
Steinem, Phosphatidylinositol 4,5-Bisphosphate Alters the Number of Attachment
Sites between Ezrin and Actin Filaments: A COLLOIDAL PROBE STUDY, J. Biol.
Chem. 289 (2014) 9833–9843.
[98] B. Liu, F. Qin, Functional control of cold- and menthol-sensitive TRPM8 ion chan-
nels by phosphatidylinositol 4,5-bisphosphate, J. Neurosci. 25 (2005) 1674–1681.
[99] P. Varnai, B. Thyagarajan, T. Rohacs, T. Balla, Rapidly inducible changes in phos-
phatidylinositol 4,5-bisphosphate levels inﬂuence multiple regulatory functions
of the lipid in intact living cells, J. Cell Biol. 175 (2006) 377–382.
[100] Y. Yudin, V. Lukacs, C. Cao, T. Rohacs, Decrease in phosphatidylinositol 4,5-
bisphosphate levels mediates desensitization of the cold sensor TRPM8 channels,
J. Physiol. 589 (2011) 6007–6027.
[101] E. Zakharian, B. Thyagarajan, R.J. French, E. Pavlov, T. Rohacs, Inorganic polyphosphate
modulates TRPM8 channels, PLoS One 4 (2009) e5404.
[102] E. Zakharian, C. Cao, T. Rohacs, Gating of transient receptor potential melastatin 8
(TRPM8) channels activated by cold and chemical agonists in planar lipid bilayers,
J. Neurosci. 30 (2010) 12526–12534.
[103] B. Nilius, F. Mahieu, J. Prenen, A. Janssens, G. Owsianik, R. Vennekens, T. Voets,
The Ca2 + -activated cation channel TRPM4 is regulated by phosphatidylinositol
4,5-biphosphate, EMBO J. 25 (2006) 467–478.
[104] D. Liu, E.R. Liman, Intracellular Ca2+ and the phospholipid PIP2 regulate the
taste transduction ion channel TRPM5, Proc. Natl. Acad. Sci. 100 (2003)
15160–15165.
[105] J. Xie, B. Sun, J. Du, W. Yang, H.-C. Chen, J.D. Overton, L.W. Runnels, L. Yue, Phos-
phatidylinositol 4,5-bisphosphate (PIP2) controls magnesium gatekeeper TRPM6
activity, Scientiﬁc Reports, 1, 2011.
[106] L.W. Runnels, L. Yue, D.E. Clapham, The TRPM7 channel is inactivated by PIP2
hydrolysis, Nat. Cell Biol. 4 (5) (2002) 329–336.
[107] J. Lee, PIP2 Activates TRPV5 and Releases Its Inhibition by Intracellular Mg2+, J.
Gen. Physiol. 126 (2005) 439–451.
[108] H.-h. Chuang, E.D. Prescott, H. Kong, S. Shields, S.-E. Jordt, A.I. Basbaum, M.V. Chao,
D. Julius, Bradykinin and nerve growth factor release the capsaicin receptor from
PtdIns(4,5)P2-mediated inhibition, Nature 411 (2001) 957–962.
[109] M. Estacion, W.G. Sinkins, W.P. Schilling, Regulation of Drosophila transient recep-
tor potential-like (TrpL) channels by phospholipase C-dependent mechanisms, J.
Physiol. 530 (2001) 1–19.
[110] V. Lukacs, B. Thyagarajan, P. Varnai, A. Balla, T. Balla, T. Rohacs, Dual Regulation of
TRPV1 by Phosphoinositides, J. Neurosci. 27 (2007) 7070–7080.
[111] R.M. Klein, C.A. Ufret-Vincenty, L. Hua, S.E. Gordon,Determinants ofMolecular Spec-
iﬁcity in Phosphoinositide Regulation: phosphatidylinositol (4,5)-bisphosphate
(PI(4,5)P2) is the endogenous lipid regulating TRPV1, J. Biol. Chem. 283 (2008)
26208–26216.
[112] C.A. Ufret-Vincenty, R.M. Klein, L. Hua, J. Angueyra, S.E. Gordon, Localization of the
PIP2 sensor of TRPV1 ion channels, J. Biol. Chem. 286 (2011) 9688–9698.
[113] E.N. Senning, M.D. Collins, A. Stratiievska, C.A. Ufret-Vincenty, S.E. Gordon, Regula-
tion of TRPV1 ion channel by phosphoinositide (4,5)-Bisphosphate: the role of
membrane asymmetry, J. Biol. Chem. 289 (2014) 10999–11006.
[114] J. Yao, F. Qin, Interaction with phosphoinositides confers adaptation onto the
TRPV1 pain receptor, PLoS Biol. 7 (2009) e46.
1827F.J. Taberner et al. / Biochimica et Biophysica Acta 1848 (2015) 1818–1827[115] B. Liu, C. Zhang, F. Qin, Functional recovery fromdesensitization of vanilloid receptor
TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate, J. Neurosci. 25
(2005) 4835–4843.
[116] S. Brauchi, G. Orta, C. Mascayano, M. Salazar, N. Raddatz, H. Urbina, E. Rosenmann,
F. Gonzalez-Nilo, R. Latorre, Dissection of the components for PIP2 activation and
thermosensation in TRP channels, Proc. Natl. Acad. Sci. 104 (2007) 10246–10251.
[117] E.D. Prescott, D. Julius, A modular PIP2 binding site as a determinant of capsaicin
receptor sensitivity, Science 300 (2003) 1284–1288.
[118] A. Garcia-Elias, S. Mrkonjić, C. Pardo-Pastor, H. Inada, U.A. Hellmich, F. Rubio-
Moscardó, C. Plata, R. Gaudet, R. Vicente, M.A. Valverde, Phosphatidylinositol-
4,5-biphosphate-dependent rearrangement of TRPV4 cytosolic tails enables
channel activation by physiological stimuli, Proc. Natl. Acad. Sci. 110 (2013)
9553–9558.
[119] P. Valente, N. Garcia-Sanz, A. Gomis, A. Fernandez-Carvajal, G. Fernandez-Ballester,
F. Viana, C. Belmonte, A. Ferrer-Montiel, Identiﬁcation of molecular determinants
of channel gating in the transient receptor potential box of vanilloid receptor I,
FASEB J. 22 (2008) 3298–3309.
[120] N. Garcia-Sanz, P. Valente, A. Gomis, A. Fernandez-Carvajal, G. Fernandez-Ballester,
F. Viana, C. Belmonte, A. Ferrer-Montiel, A role of the transient receptor potential do-
main of vanilloid receptor I in channel gating, J. Neurosci. 27 (2007) 11641–11650.
[121] L. Gregorio-Teruel, P. Valente, J.M. Gonzalez-Ros, G. Fernandez-Ballester, A. Ferrer-
Montiel, Mutation of I696 andW697 in the TRP box of vanilloid receptor subtype I
modulates allosteric channel activation, J. Gen. Physiol. 143 (2014) 361–375.
[122] F.J. Taberner, A. Lopez-Cordoba, G. Fernandez-Ballester, Y. Korchev, A. Ferrer-
Montiel, The region adjacent to the C-end of the Inner gate in transient receptor
potential melastatin 8 (TRPM8) channels plays a central role in allosteric channel
activation, J. Biol. Chem. 289 (2014) 28579–28594.
[123] A.A. Rodriguez-Menchaca, S.K. Adney, Q.-Y. Tang, X.-Y. Meng, A. Rosenhouse-
Dantsker, M. Cui, D.E. Logothetis, PIP2 controls voltage-sensor movement and
pore opening of Kv channels through the S4–S5 linker, Proc. Natl. Acad. Sci. 109
(2012) E2399–E2408.
[124] C.B. Phelps, R.R. Wang, S.S. Choo, R. Gaudet, Differential regulation of TRPV1,
TRPV3, and TRPV4 sensitivity through a conserved binding site on the ankyrin
repeat domain, J. Biol. Chem. 285 (2010) 731–740.
[125] C.B. Phelps, R.J. Huang, P.V. Lishko, R.R. Wang, R. Gaudet, Structural analyses of the
ankyrin repeat domain of TRPV6 and related TRPV Ion channels †, ‡, Biochemistry
47 (2008) 2476–2484.
[126] H. Inada, E. Procko, M. Sotomayor, R. Gaudet, Structural and biochemical conse-
quences of disease-causing mutations in the ankyrin repeat domain of the
human TRPV4 channel, Biochemistry 51 (2012) 6195–6206.
[127] Kevin W. Huynh, Matthew R. Cohen, S. Chakrapani, Heather A. Holdaway, Phoebe
L. Stewart, Vera Y. Moiseenkova-Bell, Structural Insight into the assembly of TRPV
channels, Structure 22 (2014) 260–268.[128] P.V. Lishko, E. Procko, X. Jin, C.B. Phelps, R. Gaudet, The ankyrin repeats of TRPV1
bind multiple ligands and modulate channel sensitivity, Neuron 54 (2007)
905–918.
[129] V.Y. Moiseenkova-Bell, L.A. Stanciu, I.I. Serysheva, B.J. Tobe, T.G. Wensel, Structure
of TRPV1 channel revealed by electron cryomicroscopy, Proc. Natl. Acad. Sci. 105
(2008) 7451–7455.
[130] T.L. Cvetkov, K.W. Huynh, M.R. Cohen, V.Y. Moiseenkova-Bell, Molecular architecture
and subunit organization of TRPA1 ion channel revealed by electron microscopy, J.
Biol. Chem. 286 (2011) 38168–38176.
[131] H. Shigematsu, T. Sokabe, R. Danev, M. Tominaga, K. Nagayama, A 3.5-nm structure
of rat TRPV4 cation channel revealed by zernike phase-contrast cryoelectron mi-
croscopy, J. Biol. Chem. 285 (2010) 11210–11218.
[132] E. Cao, M. Liao, Y. Cheng, D. Julius, TRPV1 structures in distinct conformations re-
veal activation mechanisms, Nature 504 (2013) 113–118.
[133] S.B. Long, X. Tao, E.B. Campbell, R. MacKinnon, Atomic structure of a voltage-
dependent K+ channel in a lipid membrane-like environment, Nature 450
(2007) 376–382.
[134] S.B. Long, E.B. Campbell, R. MacKinnon, Voltage sensor of Kv1.2: structural basis of
electromechanical coupling, Science 309 (2005) 903–908.
[135] Z. Lu, A.M. Klem, Y. Ramu, Coupling between voltage sensors and activation gate in
voltage-gated K+ channels, J. Gen. Physiol. 120 (2002) 663–676.
[136] M. Sukhareva, D.H. Hackos, K.J. Swartz, Constitutive activation of the Shaker Kv
channel, J. Gen. Physiol. 122 (2003) 541–556.
[137] D. Schmidt, Q.X. Jiang, R. MacKinnon, Phospholipids and the origin of cationic gat-
ing charges in voltage sensors, Nature 444 (2006) 775–779.
[138] S.B. Hansen, X. Tao, R. MacKinnon, Structural basis of PIP2 activation of the classical
inward rectiﬁer K+ channel Kir2.2, Nature 477 (2011) 495–498.
[139] L. Tang, T.M. Gamal El-Din, J. Payandeh, G.Q. Martinez, T.M. Heard, T. Scheuer, N.
Zheng, W.A. Catterall, Structural basis for Ca2+ selectivity of a voltage-gated calci-
um channel, Nature 505 (2014) 56–61.
[140] J. Payandeh, T.M. Gamal El-Din, T. Scheuer, N. Zheng, W.A. Catterall, Crystal struc-
ture of a voltage-gated sodium channel in two potentially inactivated states, Na-
ture 486 (2012) 135–139.
[141] J. Payandeh, T. Scheuer, N. Zheng, W.A. Catterall, The crystal structure of a voltage-
gated sodium channel, Nature 475 (2011) 353–358.
[142] J.A. Matta, P.M. Cornett, R.L. Miyares, K. Abe, N. Sahibzada, G.P. Ahern, General an-
esthetics activate a nociceptive ion channel to enhance pain and inﬂammation,
Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 8784–8789.
[143] M.J. Fischer, A. Lefﬂer, F. Niedermirtl, K. Kistner, M. Eberhardt, P.W. Reeh, C. Nau,
The general anesthetic propofol excites nociceptors by activating TRPV1 and
TRPA1 rather than GABAA receptors, J. Biol. Chem. 285 (2010) 34781–34792.
